This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Americans Now Favor Gold Over Stocks as an Investment Vehicle](
[See why investors are so impressed by this overlooked gold investment strategy.](
--------------------------------------------------------------- February 12, 2024 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [Gold Could Be Heading for Record Highs - But How to Play It?](
to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold. [See this little-known way to play in the rising gold market.](
--------------------------------------------------------------- [Aon plc](
Ticker: [AON](
Recent Price: $312.49
Average Analyst Price Target: $310.80 (-0.54%)
Market Cap: $62.57B Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 50,000 $15,098,000 4 Days Ago Recent Analyst Action: Meyer Shields, analyst at KBW, reiterates coverage on [Aon plc (AON)]( in the Financial Services sector with a Sell rating and a price target of $294 (4 days ago). Here are 3rd party ratings for [AON](: - TipRanks.com: Hold
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 33% (83 out of 250) [Click for chart >>](
-------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Here’s The Secret “Profit Driver” Behind PLTR & NVDA & ????]( This is the secret force behind every major stock move in the last 110 years. It made NVDA stockholders into millionaires, and now there’s another chance to get in. [>> Watch now.]( --------------------------------------------------------------- [Jasper Therapeutics, Inc.](
Ticker: [JSPR](
Recent Price: $17.95
Average Analyst Price Target: $63.70 (254.87%)
Market Cap: $270.32M Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Non Open Market Buy 350,000 $4,532,500 4 Days Ago Recent Analyst Action: Jay Olson, analyst at Oppenheimer, reiterates coverage on [Jasper Therapeutics, Inc. (JSPR)]( in the Healthcare sector with a Buy rating and a price target of $80 (2 months ago). Here are 3rd party ratings for [JSPR](: - TipRanks.com: Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Buy, Top 39% (97 out of 250) [Click for chart >>](
-------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [URGENT: Don't risk your retirement](
looming recession, inflation, unpayable debt, a failing dollar, and a crumbling housing market all put your savings in extreme risk. Protect your retirement with this free guide that shows you how to guard your money against economic downturns with gold. Take action NOW, before it’s too late, Download your free guide and see for yourself why gold is the #1 safe haven for smart investors. [Protect your retirement with this free gold guide](
--------------------------------------------------------------- [Roivant Sciences Ltd.](
Ticker: [ROIV](
Recent Price: $10.74
Average Analyst Price Target: $15.33 (42.77%)
Market Cap: $8.63B Role Transaction Description No. of Shares Amount Date President & COO Informative Buy Non Open Market Buy 96,950 $373,258 4 Days Ago Recent Analyst Action: Allison Bratzel, analyst at Piper Sandler, reiterates coverage on [Roivant Sciences Ltd. (ROIV)]( in the Healthcare sector with a Buy rating and a price target of $20 (1 month ago). Here are 3rd party ratings for [ROIV](: - TipRanks.com: Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 39% (97 out of 250) [Click for chart >>](
-------------------------------------------------------------------------- [ShockWave Medical, Inc.](
Ticker: [SWAV](
Recent Price: $232.80
Average Analyst Price Target: $215.75 (-7.32%)
Market Cap: $8.59B Role Transaction Description No. of Shares Amount Date Director Informative Buy Options Exercised and fully kept 81,967 $50,000 4 Days Ago Recent Analyst Action: Larry Biegelsen, analyst at Wells Fargo, reiterates coverage on [ShockWave Medical, Inc. (SWAV)]( in the Healthcare sector with a Hold rating and a price target of $200 (1 month ago). Here are 3rd party ratings for [SWAV](: - TipRanks.com: Hold
- TradingView.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Bottom 38% (154 out of 250) [Click for chart >>](
-------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.](
--------------------------------------------------------------- [Vivani Medical, Inc.](
Ticker: [VANI](
Recent Price: $1.08
Average Analyst Price Target: $4.00 (270.37%)
Market Cap: $55.10M Role Transaction Description No. of Shares Amount Date Director, >10% Owner Informative Buy Non Open Market Buy 2,190 $2,212 4 Days Ago Recent Analyst Action: Naz Rahman, analyst at Maxim Group, reiterates coverage on [Vivani Medical, Inc. (VANI)]( in the Healthcare sector with a Buy rating and a price target of $4 (2 months ago). Here are 3rd party ratings for [VANI](: - TipRanks.com: Buy
- TradingView.com: Buy
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: n/a, n/a [Click for chart >>](
-------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Strategic Gold Play You Haven't Heard About](
recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure. [Get the full story on this overlooked gold investment strategy here.](
--------------------------------------------------------------- And there you have it. To Your Financial Freedom,
The Editor InsideTraderAlerts Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. [If you are not a human, click here.]( InsideTraderAlerts part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software